Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Paskins

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Rheumatology (Oxford, England)|August 20, 2025
The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicineLaurna Bullock, Natasha Tyler, Jane Fleming, et al.
Archives of Osteoporosis|September 8, 2025
The 2024 UK clinical guideline for the prevention and treatment of osteoporosisCelia L Gregson, David J Armstrong, Christina Avgerinou, et al.
Annals of the Rheumatic Diseases|May 5, 2018
EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritisRinie Geenen, Cécile L Overman, Robin Christensen, et al.
NIHR Open Research|August 15, 2024
A person-centred consultation intervention to improve shared decision-making about, and uptake of, osteoporosis medicines (iFraP): a pragmatic, parallel-group, individual randomised controlled trial protocolLaurna Bullock, Elaine Nicholls, Andrea Cherrington, et al.
The Lancet. Rheumatology|October 24, 2022
Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative methodZoe Paskins, Clare E Farmer, Fay Manning, et al.
JBMR Plus|February 5, 2026
Time to reframe osteoporosis: a position statement to characterize the osteoporosis care gapZoe Paskins, Laurna Bullock, Ashley Hawarden, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Rheumatology (Oxford, England)|August 20, 2025
The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicineLaurna Bullock, Natasha Tyler, Jane Fleming, et al.
Archives of Osteoporosis|September 8, 2025
The 2024 UK clinical guideline for the prevention and treatment of osteoporosisCelia L Gregson, David J Armstrong, Christina Avgerinou, et al.
Annals of the Rheumatic Diseases|May 5, 2018
EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritisRinie Geenen, Cécile L Overman, Robin Christensen, et al.
NIHR Open Research|August 15, 2024
A person-centred consultation intervention to improve shared decision-making about, and uptake of, osteoporosis medicines (iFraP): a pragmatic, parallel-group, individual randomised controlled trial protocolLaurna Bullock, Elaine Nicholls, Andrea Cherrington, et al.
The Lancet. Rheumatology|October 24, 2022
Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative methodZoe Paskins, Clare E Farmer, Fay Manning, et al.
JBMR Plus|February 5, 2026
Time to reframe osteoporosis: a position statement to characterize the osteoporosis care gapZoe Paskins, Laurna Bullock, Ashley Hawarden, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Pageof 10